NIH-funded research R01 grant

Mobile-based obstetric monitoring for high blood pressure and diabetes in pregnancy

Official title: Mobile-based Obstetric Monitoring for Pregnancies Complicated by Hypertension and/or Diabetes (MOM-HD): a Type II Hybrid Implementation-Effectiveness Trial

Funded at Rutgers Biomedical and Health Sciences · NIH-11543582 · Data updated 2026-11-12

A mobile-based program helps pregnant people with high blood pressure or diabetes monitor their blood pressure and blood sugar at home and share results with their clinicians.

More Diabetes research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionRutgers Biomedical and Health Sciences
NIH-funded
Lab location1 site (Newark, UNITED STATES)
Project startSeptember 15, 2025
Project endMay 31, 2030
Funding year2026
Award (this year)$32,964
NIH project number3R01HL176741-02S1
Project IDNIH-11543582 on NIH RePORTER

Who could benefit from this research

Could help

Pregnant individuals at risk for or with hypertensive disorders or gestational diabetes in low-resource settings, particularly where access to regular healthcare visits is limited.

Less likely to help

Individuals without HDP or GDM or those unable to use telemonitoring technology may not benefit.

What this research studies

This project adapts telemonitoring to a low-resource setting to support pregnant individuals with HDP or GDM. It builds on a pilot that provided training, financial support, and technical help to enable home monitoring and clinician guidance. The goal is to keep blood pressure and glucose under control and to enable timely medical decisions without requiring frequent in-person visits. The study will combine patient self-monitoring with provider oversight to improve maternal and fetal outcomes in Nepal. If successful, it could offer a scalable model for safer, more accessible maternity care in similar settings.

Why it matters

Potential benefit: If successful, moms and babies could benefit from safer pregnancies through timely detection and management of HDP and GDM.

How similar studies have gone: Telemonitoring has improved BP and BG control in high-income countries, but evidence in low-resource settings is still emerging.

Where this research is happening

  • Rutgers Biomedical and Health Sciences
    Newark, United States
    Active

Researchers

  • Principal investigator: Rawal, Shristi — Rutgers Biomedical and Health Sciences
  • Study coordinator: Rawal, Shristi

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.